Wells Fargo’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Other funds holding EDSA
CM
TRCT
TWC
Wells Fargo's EDSA Position: Q2 2024 in Review
Wells Fargo sold out of Edesa Biotech (EDSA) in Q2 2024, closing a stake of 17 shares — an estimated $71 sold.
Wells Fargo first reported a position in EDSA in Q4 2015 and held it in 19 quarters. The position peaked at $3K in Q4 2015. 17 funds tracked by Wall St. Rank hold EDSA as of Q2 2024.
- Wells Fargo reported no remaining Edesa Biotech position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 17 Edesa Biotech shares in Q2 2024, an estimated $71.
- Wells Fargo first reported a position in Edesa Biotech in Q4 2015 and held it in 19 quarters.
- Wells Fargo's Edesa Biotech position peaked at $3K in Q4 2015.
- 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.